An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchitis - Atlantic Healthcare

HEALTHCARE PRACTITIONERS
CONTACT US

About
Research
Therapeutic Focus
- Crohn’s Disease
- Ulcerative colitis
Pipeline
Investors
News
- Conferences

Search

HEALTHCARE PRACTITIONERS
CONTACT US

P. Miner JR, M. Wedel, B. Bane & J. Bradley

Aliment Pharmacol Ther (2004) 19: 281-286

Recent Posts

Atlantic Healthcare and AcedrA BioPharmaceuticals sign MOU to explore commercial opportunities in the Middle East
15th July 2020
Atlantic Healthcare joins the panel at Virtual 2020 BMG Economic Forum, 15th July
10th July 2020
The COVID-19 virus pandemic highlights the need for a step change in the treatment of moderate to severe Inflammatory Bowel Disease
30th June 2020
Atlantic Healthcare supports World IBD Day
19th May 2020
Atlantic Healthcare appoints finance industry veteran Andrew Jones to Board of Directors
19th February 2020

Follow

Privacy Preference Center

Privacy Preferences